![(R)-5-Hydroxymethyl Tolterodine 2 inhibitor 1 O[C@H]1CCCN[C@@H]1CC(=O)CN1C=NC2=CC(Br)=C(Cl)C=C2C1=O](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10635_1621562209.gif?v=1626761616)
Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
O[C@H]1CCCN[C@@H]1CC(=O)CN1C=NC2=CC(Br)=C(Cl)C=C2C1=O
InChi: InChI=1S/C20H28O5/c1-9-7-19-10(2)5-13-14(18(13
which is probably responsible for many of its unique properties
Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer
3-benzothiazol-2-yl)-1-phenylurea
(R)-5-Hydroxymethyl Tolterodine 2 inhibitor 1 O[C@H]1CCCN[C@@H]1CC(=O)CN1C=NC2=CC(Br)=C(Cl)C=C2C1=ODesfesoterodine, also known as PNU 200577, is a major pharmacologically active metabolite of tolterodine, a new muscarinic receptor antagonist intended for the treatment of an overactive bladder. In vitro, PNU 200577 produced a competitive and concentration dependent inhibition of carbachol induced contraction of guinea pig isolated urinary bladder strips (KB = 0. 84 nM; pA2 = 9. 14). In vivo, PNU 200577 was significantly more potent at inhibiting